Overview

Treatment for Subjects With Active Rheumatoid Arthritis (RA)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety of etanercept liquid administered once weekly to subjects with RA.
Phase:
Phase 3
Details
Lead Sponsor:
Amgen
Treatments:
Etanercept